Summary Of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2012

Summary Of Significant Accounting Policies [Abstract]

Summary Of Net Revenues By Product Category

	For The Three Months Ended March 31,
	2012		2011
	(In thousands)
Respiratory and other chronic therapies	$	449,544	$	386,020
DME, infusion and enteral therapies		51,334		45,547
Total	$	500,878	$	431,567

Schedule Of Operating Expenses By Category

Operating Expenses (in thousands)	For The Three Months Ended March 31,
	2012		2011
Salary and related	$	74,717	$	66,430
Facilities		16,410		15,765
Vehicles		15,020		12,664
General supplies/miscellaneous		8,835		7,048
Total	$	114,982	$	101,907